Reversible cerebral vasoconstriction syndrome (RCVS): treatment
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Reversible cerebral vasoconstriction syndrome (RCVS): treatment. Discontinue triggering agents. Fully referenced neurology checklist.
Treatment
- Discontinue triggering agents
- Calcium channel blockers: Nimodipine, Nifedipine, or Verapamil
- Steroids: these are controversial as they may worsen RCVS
Treatment of refractory cases
Locked: subscribe to see this section.
References
- Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: a prospective sites of 67 patients. Brain 2007; 130:3091-3101.
- Ducros A, Bousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol 2009; 9:256-267.
- Sattar A, Manousakis G, Jensen MB. Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther 2010; 8:1417-1421.
- Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology 2016; 88:228-236.
- Bouchard M, Verreault S, Gariépy JL, Dupré N. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. Headache 2009; 49:142-145.
- And 4 more. Subscribe to see the full list
